Pathologic changes in breast cancer after anti-estrogen therapy

Breast Journal

Volumn 18, Issue 4, 2012, Pages 362-366

  Samarnthai, Norasate ^a   Elledge, Richard ^b   Prihoda, Thomas J ^b   Huang, Jian ^c   Massarweh, Suleiman ^d   Yeh, I Tien ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

anti estrogen therapy; breast cancer; histopathology

Indexed keywords

ANASTROZOLE; ESTROGEN RECEPTOR; FULVESTRANT; GEFITINIB;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SURGERY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; NEEDLE BIOPSY; POSTMENOPAUSE; TREATMENT RESPONSE; TUMOR MICROENVIRONMENT; TUMOR REGRESSION;

AGED; AGED, 80 AND OVER; BIOPSY, LARGE-CORE NEEDLE; BREAST NEOPLASMS; CELL DIFFERENTIATION; CYTOPLASM; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; MIDDLE AGED; NITRILES; POSTMENOPAUSE; RECEPTORS, ESTROGEN; TREATMENT OUTCOME; TRIAZOLES;

EID: 84863722120     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2012.01251.x     Document Type: Article

References (20)

1. Elkak AE, Mokbel K,. Pure antiestrogens and breast cancer. Curr Med Res Opin 2001; 17: 282-9.
2. Barnadas A, Gil M, Sanchez-Rovira P, et al. Neoadjuvant endocrine therapy for breast cancer: past, present and future. Anticancer Drugs 2008; 19: 339-47.
3. Thompson EW, Reich R, Shima TB, et al. Differential regulation of growth and invasiveness of MCF-7 breast cancer cells by antiestrogens. Cancer Res 1988; 48: 6764-8.
4. Clarke R, Liu MC, Bouker KB, et al. Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling. Oncogene 2003; 22: 7316-39.
5. Valenzuela M, Julian TB,. Neo-adjuvant hormonal therapy. Breast J 2008; 14: 279-83.
6. Dixon JM, Anderson TJ, Miller WR,. Neoadjuvant endocrine therapy of breast cancer: a surgical perspective. Eur J Cancer 2002; 38: 2214-21.
7. Mathew J, Asgeirsson KS, Jackson LR, et al. Neoadjuvant endocrine treatment in primary breast cancer-review of literature. Breast 2009; 18: 339-44.
8. Connolly R, Stearns V,. A multidisciplinary approach to neoadjuvant therapy for primary operable breast cancer. Challenges and opportunities. Oncology (Williston Park) 2010; 24: 135-43.
9. Elston CW, Ellis IO,. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991; 19: 403-10.
10. Allred DC, Harvey JM, Berardo M, et al. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 1998; 11: 155-68.
11. Anderson TJ, Dixon JM, Stuart M, et al. Effect of neoadjuvant treatment with anastrozole on tumour histology in postmenopausal women with large operable breast cancer. Br J Cancer 2002; 87: 334-8.
12. Emerson WJ, Kennedy BJ, Taft EB,. Correlation of histological alterations in breast cancer with response to hormone therapy. Cancer 1960; 13: 1047-52.
13. Miller WR, Dixon JM, Macfarlane L, et al. Pathological features of breast cancer response following neoadjuvant treatment with either letrozole or tamoxifen. Eur J Cancer 2003; 39: 462-8.
14. Aktepe F, Kapucuoglu N, Pak I,. The effects of chemotherapy on breast cancer tissue in locally advanced breast cancer. Histopathology 1996; 29: 63-7.
15. Fisher ER, Wang J, Bryant J, et al. Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18. Cancer 2002; 95: 681-95.
16. Gajdos C, Tartter PI, Estabrook A, et al. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer. J Surg Oncol 2002; 80: 4-11.
17. Kennedy S, Merino MJ, Swain SM, et al. The effects of hormonal and chemotherapy on tumoral and nonneoplastic breast tissue. Hum Pathol 1990; 21: 192-8.
18. Moll UM, Chumas J,. Morphologic effects of neoadjuvant chemotherapy in locally advanced breast cancer. Pathol Res Pract 1997; 193: 187-96.
19. Rasbridge SA, Gillett CE, Seymour AM, et al. The effects of chemotherapy on morphology, cellular proliferation, apoptosis and oncoprotein expression in primary breast carcinoma. Br J Cancer 1994; 70: 335-41.
20. Friedman N,. The effects of irradiation on breast cancer and the breast. CA Cancer J Clin 1988; 38: 368-71.